Prognosis of metastatic renal cell carcinoma with first‐line interferon‐α therapy in the era of molecular‐targeted therapy-Reference-Cited by-同舟云学术

Prognosis of metastatic renal cell carcinoma with first‐line interferon‐α therapy in the era of molecular‐targeted therapy

Published:2016-06-14 Issue:7 Volume:107 Page:1013-1017
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Kawano Yoshiaki¹,Takahashi Wataru¹,Eto Masatoshi¹²,Kamba Tomomi³,Miyake Hideaki⁴,Fujisawa Masato⁴,Kamai Takao⁵,Uemura Hirotsugu⁶,Tsukamoto Taiji⁷,Azuma Haruhito⁸,Matsubara Akio⁹,Nishimura Kazuo¹⁰,Nakamura Tsuyoshi¹¹,Ogawa Osamu³,Naito Seiji²

Affiliation:

1. Department of Urology Faculty of Life Sciences Kumamoto University KumamotoJapan

2. Department of Urology Graduate School of Medical Sciences Kyushu University FukuokaJapan

3. Department of Urology Graduate School of Medicine Kyoto University KyotoJapan

4. Division of Urology Department of Surgery Related Kobe University Graduate School of Medicine KobeJapan

5. Department of Urology Dokkyo Medical University Shimotsuka‐ gun TochigiJapan

6. Department of Urology Kinki University School of Medicine Osaka‐SayamaJapan

7. Department of Urologic Surgery and Andrology Sapporo Medical University School of Medicine SapporoJapan

8. Department of Urology Osaka Medical College TakatsukiJapan

9. Department of Urology Graduate School of Biomedical Sciences Hiroshima University HiroshimaJapan

10. Department of Urology Osaka Medical Center for Cancer and Cardiovascular Diseases OsakaJapan

11. Graduate School of Science and Engineering Chuo University Tokyo Japan

Funder

Ministry of Education, Culture, Sports, Science, and Technology

Pfizer

Novartis

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12951

Reference33 articles.

1. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review

2. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

3. Treatment options for metastatic renal cell carcinoma: a review;Athar U;Can J Urol,2008

4. Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma

5. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Staging of renal cell carcinoma: current progress and potential advances;Pathology;2021-01

2. Novel survival nomograms for patients with lung metastatic clear cell renal cell carcinoma;Medicine;2020-12-24

Overexpression of COL5A1 promotes tumor progression and metastasis and correlates with poor survival of patients with clear cell renal cell carcinoma

;Cancer Management and Research;2019-02

4. Evaluation and predictive factors analyses for patient-self-reported depression, anxiety and quality of life in patients with metastatic renal cell carcinoma underwent interferon-α treatment: a prospective cohort study;Translational Cancer Research;2018-12

5. Current systemic therapies for metastatic renal cell carcinoma in older adults: A comprehensive review;Journal of Geriatric Oncology;2018-05